Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

Fig. 1

Distribution of participants according to CSF levels of Aβ1–42 and amyloid ratio within diagnostic categories. CN, cognitively normal; AD, Alzheimer’s disease; DLB, dementia with Lewy bodies; FTLD, frontotemporal lobar degeneration-related syndrome. Dashed lines indicate 95% quantile values (Q95%) for Aβ1–42 and Aβ1–42/Aβ1–40 in a middle-aged cognitively normal population as described in the “Material and methods” section

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193